Statera Biopharma Inc. Skyrocketed
Thu, May 25, 2023 at 07:45 PM
Statera Biopharma Inc. (STAB:NASDAQ) rocketted at $0.03, representing a gain of 53.8%. On Thu, May 25, 2023, STAB:NASDAQ hit a New 2-Week High of $0.03. From Thu, May 11, 2023, the stock recorded 20.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Mar 15, 2023 at $0.05 with a volume of 7M+.
About Statera Biopharma Inc. (STAB:NASDAQ)
Statera BioPharma Inc is a clinical-stage biopharmaceutical company addressing autoimmune and inflammatory diseases, blood disorders, infectious diseases, and cancer.
Top 10 Gainers:
- Wearable Devices Ltd. (WLDS:NASDAQ), 222.65%
- Beamr Imaging Ltd. (BMR:NASDAQ), 125.45%
- Nano Labs Ltd (NA:NASDAQ), 69.29%
- Team, Inc. (TISI:NYSE), 61.78%
- SunCar Technology Group Inc Ord (SDA:NASDAQ), 61.41%
- Statera Biopharma Inc. (STAB:NASDAQ), 53.85%
- Kubient Inc. (KBNT:NASDAQ), 44.27%
- SemiLEDs Corporation (LEDS:NASDAQ), 43.63%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 38.41%
- Heart Test Laboratories, Inc. (HSCS:NASDAQ), 36.13%